METTL3 and colorectal carcinoma: A growing number of studies have shown that human intestinal microbiota can regulate the occurrence and progression of CRC by their metabolites.[96] Consistently, Zhu et al discovered that the butyrate, classical production of the microbiome, decreased m6A levels and METTL3 expression in CRC cells in a dose-independent manner.